To evaluate the good prognosis of lung adenocarcinoma (LUAD) and skin cutaneous melanoma (SKCM) with high IL‐2 expression, infiltration of antitumor immune cells within the tumor sites were examined. The gene discussed is IL2; the disease is cutaneous melanoma.